- Authorized for weight loss
- Wegovy and Zepbound (weekly), Saxenda (daily)
- Cash price, about 4 weeks
- $314 to $742, depending on brand and dose
- Prescription
- Needed for all three: family doctor, nurse practitioner, walk-in or licensed online clinic
- Public drug plans
- Narrow at best: only small groups, and only if the price drops
- Do not buy
- Research use only vials and pens sold without a prescription
Three weight loss injections are authorized and on sale in Canada: Wegovy (semaglutide, once a week), Zepbound (tirzepatide, once a week) and Saxenda (liraglutide, once a day)1,2,3,4. All three need a prescription. Paying cash, a 4-week supply costs about $314 to $742, depending on the brand and the dose5.
Public drug plans pay only for small groups, if at all6,7, so most people pay out of pocket or through a work plan. Skip the “research use only” vials sold online. Health Canada keeps seizing them8,9.
Weight loss injections in Canada: the short list
Weight loss injections in Canada come down to three brands you can fill at a pharmacy today: Wegovy, Zepbound and Saxenda. Each is a prescription drug from the GLP-1 family, built to act like a hormone your gut releases after you eat2,4. Zepbound also acts on a second gut hormone, GIP7.
| Brand | Drug inside | How often | Authorized in Canada for | Sold in pharmacies now? |
|---|---|---|---|---|
| Wegovy | semaglutide | Once a week | Weight management; lowering heart-attack risk in adults with heart disease; MASH, a type of fatty liver disease | Yes |
| Zepbound | tirzepatide | Once a week | Weight management; obstructive sleep apnea in adults with obesity | Yes, since July 2025 |
| Saxenda | liraglutide | Once a day | Weight management | Yes, since 2015 |
| Sevmia | semaglutide (generic) | Once a week | Weight management | No. Approved, not marketed |
Here is where each one stands. Wegovy has been authorized since November 2021, and its Canadian label now also covers heart-attack risk and a form of fatty liver disease10,2.
Zepbound got its Canadian approval on May 13, 2025, and reached pharmacies on July 9, 202510,1. Saxenda is the oldest of the three, approved in February 201510.
Sevmia is the one that trips people up. It is Apotex’s generic semaglutide with a weight-loss label, approved on June 29, 2026.
As of November 12, 2026, it is listed as approved but not marketed, so no pharmacy can fill it yet1,10. There is no generic liraglutide in Canada either, though 10 generic versions are waiting for Health Canada review1,11.

Who can get a weight loss injection prescribed
You qualify on paper if your body mass index (BMI) is 30 or more, or 27 or more with at least one weight-related health problem, such as high blood pressure or prediabetes. That is the bar in all three Canadian labels2,3,4,7. The final call is your prescriber’s.
The labels differ in a few places that matter when you sit down with a doctor:
- Saxenda is labelled for adults who have already tried another way to lose weight and it did not work4. Be ready to describe what you tried.
- Wegovy is the only one of the three with a heart-risk label: lowering the risk of a non-fatal heart attack in adults with established heart disease and a BMI of 27 or more2.
- Zepbound is the only one labelled for moderate to severe obstructive sleep apnea in adults with obesity3.
- Teens. Wegovy and Saxenda have labels for ages 12 to under 18 who meet weight and BMI limits. Zepbound has no label for anyone under 182,4,3.
Your prescriber will also ask about your history. All three Canadian monographs warn about thyroid C-cell tumours seen in rodent studies2,3,4, so expect questions about thyroid cancer in you or your family. Bring a list of your medicines too.
What about Ozempic, Mounjaro and “generic Ozempic”?
Ozempic and Mounjaro are not weight loss injections in Canada, at least not on their labels. Both are authorized for type 2 diabetes10,12. They hold the same drugs as Wegovy (semaglutide) and Zepbound (tirzepatide), so a doctor can prescribe them for weight, but that use is off-label.
The same goes for the generic semaglutide pens that reached Canadian shelves in May 2026. Dr. Reddy’s and Apotex both sell one, and both are labelled for type 2 diabetes, not weight1,10. They are much cheaper.
Apo-Semaglutide costs about $92 to $123 a pen, cash5. The catch is that its pens go up to a 1 mg dose1, while Wegovy’s weight-loss dose is 2.4 mg2.
Wondering which of the two big brands works better? That is its own question, and we answer it in our page on how Mounjaro and Ozempic compare.
Which weight loss injection works best?
On average weight loss in their main trials, the order is Zepbound, then Wegovy, then Saxenda. These numbers come from separate placebo-controlled trials, so read them as a rough ranking, not a contest held on the same day:
- Zepbound (tirzepatide): 20.9% of body weight lost on the 15 mg dose over 72 weeks, against 3.1% on placebo, in SURMOUNT-113.
- Wegovy (semaglutide 2.4 mg): 14.9% over 68 weeks, against 2.4% on placebo, in STEP 114.
- Saxenda (liraglutide 3.0 mg): 8.0% over 56 weeks, against 2.6% on placebo, in the SCALE trial4. In kilograms that was 8.4 kg against 2.8 kg15.
| Peptide | Health Canada | |||||
|---|---|---|---|---|---|---|
TirzepatideZepbound, Mounjaro | ~17 moFull dose after 20 weeks | EasyWeekly pen | $314–742Cash, before insurance | Approved (Zepbound) | A | |
Semaglutide injectionWegovy, Ozempic, Sevmia, Apo-Semaglutide | ~16 moFull dose after 16 weeks | EasyWeekly pen | $380–507Cash, before insurance | Approved | A | |
LiraglutideSaxenda | ~13 moCheck progress at 12 weeks | Some rulesDaily pen | $395–524Cash, before insurance | Approved | A |
Our view: for most adults who qualify, the real choice is between the two weekly pens, and the daily Saxenda pen makes sense mainly when the others are not an option for you. Trial averages are not promises, though.
Some people lose much more, some much less. If you want the full case for each drug, including how the newer GLP-1s in trials stack up, read our guide to choosing the best GLP-1 for weight loss.
What the first months feel like
All three start at a low dose and climb. Wegovy starts at 0.25 mg a week and steps up every 4 weeks until it reaches 2.4 mg after 16 weeks2. Zepbound starts at 2.5 mg a week for 4 weeks, then rises in 2.5 mg steps3.
Your prescriber sets the pace. Do not change it on your own.
Stomach side effects are the common ones, mostly while the dose rises. On the Zepbound label, nausea showed up in 24.6% to 29.0% of people in the trials, against 8.5% on placebo3. In STEP 1, 4.5% of people on semaglutide stopped because of stomach problems, against 0.8% on placebo14.
How much weight loss injections cost in Canada
Paying cash, expect roughly $314 to $742 for about four weeks of treatment, depending on brand and dose5. Wegovy costs the same at every strength in our price data.
Zepbound costs more as the dose goes up. These are prices before any insurance, with the pharmacy’s dispensing fee included.
| Brand (use in Canada) | Dose | What you get | Cash price | Basis |
|---|---|---|---|---|
| Wegovy (weight) | any strength | 1 pen, 4 weekly doses | $380–507 | Audited at Costco, Walmart, London Drugs, Rexall and Shoppers; estimated elsewhere |
| Zepbound (weight) | 2.5 or 5 mg | 1 pen, 4 weekly doses | $314–418 | Estimated |
| Zepbound (weight) | 7.5 or 10 mg | 1 pen, 4 weekly doses | $439–581 | Estimated |
| Zepbound (weight) | 12.5 or 15 mg | 1 pen, 4 weekly doses | $563–742 | Estimated |
| Saxenda (weight) | up to 3 mg daily | 5 pens, 30 daily doses | $395–524 | Estimated |
| Sevmia (generic Wegovy) (weight) | 1 mg only | Not sold yet | No price | Approved, not marketed |
What do the labels mean? The prices come from one pricing dataset run across every province and pharmacy chain. “Audited” rows use drug prices from a retail phone audit dated August 2026.
“Estimated” rows are modelled from list prices5. Nobody has published an audited Canadian price for Zepbound or Saxenda yet, so treat those rows as a guide.
One cross-check for Zepbound: in its 2026 review, Canada’s Drug Agency listed Lilly’s submitted price as $300 a pen for the 2.5 and 5 mg doses, $420 for 7.5 and 10 mg, and $540 for 12.5 and 15 mg7. Those are list prices before the pharmacy adds its markup and fee, so they sit a little under the estimates. Our Zepbound Canada guide breaks its cost down by dose and covers Lilly’s savings card.
What a year costs
A year of weekly pens is 13 four-week supplies. That is our own arithmetic on the ranges above, not a quote:
| Injection, steady dose | 13 supplies, low end | 13 supplies, high end |
|---|---|---|
| Wegovy | $4,940 | $6,591 |
| Zepbound 2.5 or 5 mg | $4,082 | $5,434 |
| Zepbound 12.5 or 15 mg | $7,319 | $9,646 |
Saxenda’s 30-day pack works out to about $4,740 to $6,288 for 12 packs (360 days) on the same basis5.
Three things move your real price. The first is the chain, since the dispensing fee in this data runs from $4.49 at Costco to $13.99 at Shoppers among the store chains5.
The second is your dose, for Zepbound. The third is your drug plan, which we cover below.
Saxenda’s 12-week checkpoint
Saxenda’s label has a stopping rule. If you have not lost at least 5% of your body weight after 12 weeks on the full 3.0 mg daily dose, the label says to stop4. That protects your wallet: you will know within a few months whether it is worth paying for.
The cost of stopping
Here is the part most buying guides skip. These drugs work while you take them, and much of the weight tends to come back after you stop.
The clearest numbers come from the STEP 1 extension. People who had lost 17.3% of their weight on semaglutide stopped treatment, and within a year they had regained 11.6 percentage points, about two-thirds of what they lost16. A tirzepatide trial found the same pattern, and our GLP-1 guide covers what happens when you stop in more depth.
Plan your budget around a year or more of treatment. If the monthly cost only works for a few months, raise that with your prescriber before the first pen.

Six questions about your goals, budget and comfort with needles.
Does insurance or a provincial plan cover weight loss injections?
For most Canadians, public drug plans do not pay for weight loss injections, and private plans vary6,17,18. Canada’s Drug Agency (CDA-AMC) reviews new drugs and advises the provinces, but each public plan makes its own decision after price talks7.
| Drug | What Canada’s Drug Agency said | Conditions |
|---|---|---|
| Wegovy | Reimburse with conditions (July 2025) | Only adults with a BMI of 27 or more and established heart disease; price must drop |
| Zepbound | Reimburse with conditions (August 2026) | Only adults with a BMI of 27 or more and prediabetes; price must drop |
| Saxenda | Do not reimburse (September 2021) | None |
Wegovy shows how hard this is. In July 2025, CDA-AMC said public plans could cover it for adults with a BMI of 27 or more who have had a heart attack, a stroke or symptomatic peripheral artery disease.
It also said the price would need to fall by 67% to meet the agency’s usual value bar, and put the cost at about $5,066 per patient per year at list price6. Then, in late 2025, the price talks on behalf of public plans ended without a deal after Novo Nordisk declined to negotiate17.
Zepbound got its recommendation on August 28, 2026. CDA-AMC backed coverage for adults with a BMI of 27 or more and prediabetes who have tried dieting at least once without success, if the price comes down.
To stay covered after the first year, a person would need to show at least 5% weight loss7. Whether and when any province lists it still depends on price talks.
Saxenda got a “do not reimburse” in 2021. The reviewers said no conclusions could be drawn about long-term benefits, such as fewer weight-related health problems18.
Private and workplace plans
Coverage through work depends on your plan, not on the drug. Before you fill a prescription, call your insurer or check your plan’s app and ask:
- Is this exact drug (Wegovy, Zepbound or Saxenda) on my plan’s drug list?
- Does the plan cover drugs for weight management, or only for diabetes?
- Does my doctor need to fill in a prior authorization form first?
- Is there a yearly maximum, and what share do I pay at the counter?
Write the answers down. If the plan says no, ask whether there is an appeal process.
How to get a prescription for weight loss injections in Canada
You need a prescription from a licensed prescriber, and you fill it at a licensed pharmacy. Health Canada puts it plainly: “Only buy prescription drugs from a licensed pharmacy”19. There are three common ways in.
- Your family doctor or nurse practitioner. This is the best route if you have one. They know your history and can follow your progress, side effects and blood work over time.
- A walk-in clinic. If you searched “weight loss injections near me”, this is often the fastest local option. Some walk-in doctors will start a weight loss drug, and others prefer to send you back to a regular provider for follow-up. Call ahead and ask.
- A licensed Canadian online clinic. These assess you by video or questionnaire, then send the prescription to a pharmacy. This can work well, as long as it is a real medical service and not a store.
Whichever route you take, bring the facts a prescriber will want: your height and weight, what you have tried before, health problems like high blood pressure, prediabetes or sleep apnea, your medicines, and any family history of thyroid cancer.
How to vet an online clinic
We do not name or rank clinics, and we have no deal with any of them. Use this checklist instead:
- The prescriber is a doctor or nurse practitioner licensed in your province, and you can see their name.
- You get a real assessment that asks about your health, not just a payment page.
- The drug ships from a licensed Canadian pharmacy, and the box shows an eight-digit DIN that you can look up in Health Canada’s Drug Product Database20,19.
- Prices for the consult and the drug are shown up front, separately.
- Follow-up is included, so someone adjusts the dose and checks on side effects.
Be wary of any site that uses Health Canada’s logo as an endorsement. Health Canada says some sellers misuse its logos and fake endorsements, and that it never endorses a health product19.
B12, MIC and “lipo” shots for weight loss
Some clinics sell vitamin B12 shots, or “lipotropic” shots, as a cheaper kind of weight loss injection. The evidence does not show that either one makes you lose weight.
B12 shots. A B12 injection is a real drug with a DIN in Canada, but its label is for treating a lack of B12, such as pernicious anemia or poor absorption after stomach surgery. Weight loss is not on it21.
So, do B12 injections help with weight loss? Cleveland Clinic says the shots are not linked to weight loss, and that they do nothing if your B12 level is already normal22.
They are often given without a clear need, too. In an Ontario study of 146,850 adults aged 65 and older who got B12 shots, about a quarter had a normal level in the year before the first shot, and 38% had no B12 test on record that year23.
MIC and lipo shots. MIC injections for weight loss usually mix methionine, inositol and choline, often with B12 added. We found no published trial showing that these shots cause weight loss in people.
Even as a pill, choline’s link to weight loss rests on limited and inconsistent evidence24. Health Canada’s Drug Product Database lists no human injection that combines methionine, inositol and choline1.
Our take: skip them. If you think you might be low in B12, a blood test can tell you.
What not to buy: research peptide vials and fake pens
Do not buy weight loss injections from “research peptide” shops, social media sellers or anyone who skips the prescription. These products are not authorized in Canada, and Health Canada has found contaminated ones8,9.
The “research use only” label is the big trap. Health Canada says that kind of labelling “does not make these products legal”20.
Vials sold as retatrutide are a common case. Retatrutide is still in trials and is not approved in Canada or the US25,1, yet Health Canada has seized it from sellers more than once26,8.
The risks are not just legal. Health Canada lists infection, a wrong or missing dose, hidden ingredients and contamination among the dangers of unauthorized injectables20. A cheap vial is not cheap if it puts you in hospital.
We cover the law, the seizures and what to do if you already bought something in our guide to whether peptides are legal in Canada.
How we put this guide together
We checked every brand and its status against Health Canada’s Drug Product Database and Notice of Compliance database on November 12, 20261,10. Eligibility and dosing come from the Canadian product monographs, quoted, not advised. Weight-loss figures come from the journal papers.
Prices come from one pricing dataset, and each row says whether it was audited or estimated5. Coverage facts come from Canada’s Drug Agency’s published recommendations.
Nobody on our team took or gave these injections for this guide. A pharmacist has not checked it yet, so the page carries a “Pharmacist review pending” label until that happens. Our grading method explains how we rate the evidence.
Your next step toward a weight loss injection
If you qualify and can budget for at least a year, book a visit with your family doctor, a walk-in clinic or a licensed online clinic and ask about Zepbound, Wegovy or Saxenda by name. Check your drug plan before you fill the prescription. If you are still unsure which fits you, take our one-minute quiz first.
Frequently asked questions
What is the best weight loss injection in Canada?
On trial results, Zepbound (tirzepatide) led to the most weight loss of the three injections sold in Canada, followed by Wegovy (semaglutide) and then Saxenda (liraglutide). The best one for you also depends on price, your drug plan, your other health conditions and whether you would rather inject once a week or once a day. Your prescriber can help you weigh those.
How much does a weight loss injection cost per month in Canada?
Paying cash, a 4-week supply of Wegovy runs about $380 to $507, Zepbound about $314 to $742 depending on the dose, and a 30-day supply of Saxenda about $395 to $524. Those figures include a pharmacy dispensing fee and come before any insurance. Zepbound and Saxenda prices are estimates, not audited quotes.
Do you need a prescription for weight loss injections in Canada?
Yes. Wegovy, Zepbound and Saxenda are prescription drugs, and only a licensed pharmacy can legally sell them to you. Anyone offering these drugs without a prescription, or selling look-alike vials online, is not a legal source.
Are weight loss injections covered by OHIP or other provincial plans?
Not for most people. Canada's Drug Agency has recommended public coverage of Wegovy and Zepbound only for small groups of patients, and only if the price comes down.
The talks on Wegovy's price ended without a deal in 2025. Private workplace plans vary, so call your insurer and ask about the exact drug.
Can I get a weight loss injection prescribed online in Canada?
Yes, through a licensed Canadian online clinic that does a real medical assessment, then sends the prescription to a licensed pharmacy. Check that the prescriber is licensed in your province and that the box you receive has an eight-digit DIN. Skip any site that sells the drug without an assessment.
Is generic semaglutide available for weight loss in Canada?
Not yet. Sevmia, the generic semaglutide with a weight-loss label, is approved but was not on sale as of November 2026. The generic semaglutide pens you can buy now are labelled for type 2 diabetes and go up to a 1 mg dose, so using them for weight is off-label.
- Drug Product Database (product, status, route, form and active-ingredient records via the DPD API; searched for semaglutide, tirzepatide, liraglutide, tesamorelin, orforglipron, cagrilintide, retatrutide, survodutide, AOD, BPC, MOTS, ipamorelin, CJC, methylquinolinium), Health Canada, accessed 2026-11-12
- WEGOVY (semaglutide injection) Product Monograph, Novo Nordisk Canada Inc. (Health Canada DPD), date of authorization 2026-10-02
- ZEPBOUND (tirzepatide injection) Product Monograph, Eli Lilly Canada Inc. (Health Canada DPD), date of authorization 2026-06-11
- SAXENDA (liraglutide injection) Product Monograph, Novo Nordisk Canada Inc. (Health Canada DPD), date of authorization 2025-09-10
- How we price: Canadian cash prices modelled from list prices and each chain's dispensing fee, with drug prices from a published August 2026 retail phone audit where one exists, Peptides for Weight Loss (methodology), 2026-11-12
- Semaglutide (Wegovy): Reimbursement Recommendation (chronic weight management), Canada's Drug Agency (CDA-AMC), Canadian Journal of Health Technologies 5(7), 2025-07-04
- Tirzepatide (Zepbound): Reimbursement Recommendation (chronic weight management), Canada's Drug Agency (CDA-AMC), Canadian Journal of Health Technologies 6(8), 2026-08-28
- Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs (RA-82930), Health Canada (public advisory), 2026-11-06
- Health Canada warns about unauthorized peptides, including contaminated injectable peptides sold by Sage & Summit Wellness Co. in Ottawa, ON (RA-82944), Health Canada (public advisory), 2026-11-12
- Notice of Compliance database (all NOCs for semaglutide, tirzepatide, liraglutide and tesamorelin, via the NOC API), Health Canada, accessed 2026-11-12
- Generic submissions under review (list current as of 2026-09-30), Health Canada, accessed 2026-11-12
- MOUNJARO (tirzepatide injection) Product Monograph, Eli Lilly Canada Inc. (Health Canada DPD), date of authorization 2026-06-23
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), New England Journal of Medicine 387(3):205-216, 2022-07-21
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), New England Journal of Medicine 384(11):989-1002, 2021-03-18
- Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE), New England Journal of Medicine 373(1):11-22, 2015-07-02
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension, Diabetes, Obesity and Metabolism 24(8):1553-1564, 2022-08 (online 2022-05-19)
- Wegovy won't be in Canadian public drug plans as Novo Nordisk refuses talks, Global News, 2025-12-03
- Liraglutide (Saxenda): CADTH Reimbursement Recommendation (chronic weight management), CADTH, Canadian Journal of Health Technologies 1(9), 2021-09-20
- Thinking about buying GLP-1 drugs like Ozempic or Mounjaro? Beware of fake or unauthorized products (RA-81518), Health Canada (public advisory), 2026-01-21
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you (RA-81874), Health Canada (public advisory), 2026-04-09
- CYANOCOBALAMIN INJECTION USP (vitamin B12) Prescribing Information, Hikma Canada Limited (Health Canada DPD), 2022-04-20
- Vitamin B12 Injections: What They Can and Can't Do, Cleveland Clinic, 2024-03-05
- Silverstein WK et al. Prevalence of Inappropriateness of Parenteral Vitamin B12 Administration in Ontario, Canada, JAMA Internal Medicine 179(10):1434-1436, 2019-10 (online 2019-07-15)
- Mah E et al. Dietary Supplements for Weight Management: A Narrative Review of Safety and Metabolic Health Benefits, Nutrients 14(9):1787, 2022-04-24
- Jastreboff AM et al. Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity (TRIUMPH-1), New England Journal of Medicine 395(18):1781-1793, 2026-11-05 (online 2026-09-29)
- Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks (RA-77807), Health Canada (public advisory), 2025-08-01
For information only, not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any treatment. Prices are cash prices before insurance and change often.
Some provider links may earn us a referral fee, which never changes a grade or a ranking. Medical disclaimer · How we source
